Authors:
Bakos, E
Evers, R
Sinko, E
Varadi, A
Borst, P
Sarkadi, B
Citation: E. Bakos et al., Interactions of the human multidrug resistance proteins MRP1 and MRP2 withorganic anions, MOLEC PHARM, 57(4), 2000, pp. 760-768
Authors:
Bakos, E
Evers, R
Calenda, G
Tusnady, GE
Szakacs, G
Varadi, A
Sarkadi, B
Citation: E. Bakos et al., Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1), J CELL SCI, 113(24), 2000, pp. 4451-4461
Authors:
Evers, R
Kool, M
Smith, AJ
van Deemter, L
de Haas, M
Borst, P
Citation: R. Evers et al., Inhibitory effect of the reversal agents V-104, GF120918 and pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport, BR J CANC, 83(3), 2000, pp. 366-374
Authors:
Evers, R
de Haas, M
Sparidans, R
Beijnen, J
Wielinga, PR
Lankelma, J
Borst, P
Citation: R. Evers et al., Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export, BR J CANC, 83(3), 2000, pp. 375-383
Authors:
Paulusma, CC
van Geer, MA
Evers, R
Heijn, M
Ottenhoff, R
Borst, P
Elferink, RPJO
Citation: Cc. Paulusma et al., Canalicular multispecific organic onion transporter multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione, BIOCHEM J, 338, 1999, pp. 393-401
Authors:
Raggers, RJ
van Helvoort, A
Evers, R
van Meer, G
Citation: Rj. Raggers et al., The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane, J CELL SCI, 112(3), 1999, pp. 415-422